SEC Company Response from Q (QCLS) — Dec 14, 2017
Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: Dec. 14, 2017 · CIK: 0001321834 · Accession: 0001213900-17-013264
AI Filing Summary & Sentiment
Reasoning
Letter
Akers Biosciences, Inc.
201 Grove Road
Thorofare, NJ 08086
(856) 848-2116
December 14, 2017
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Irene Paik and Erin Jaskot
Re: Akers Biosciences, Inc. – Withdrawal of Acceleration Request
Registration Statement on Form S-1
File No. 333- 221746
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on December 13, 2017, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday, December 14, 2017, at 5:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
AKERS BIOSCIENCES, INC.
By: /s/ John J. Gormally
John J. Gormally
Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
Akers Biosciences, Inc.
201 Grove Road
Thorofare, NJ 08086
(856) 848-2116
December 14, 2017
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Irene Paik and Erin Jaskot
Re:
Akers Biosciences, Inc. – Withdrawal of Acceleration Request
Registration Statement on Form S-1
File No. 333- 221746
Ladies and Gentlemen:
Reference is made to our
letter, filed as correspondence via EDGAR on December 13, 2017, in which we requested the acceleration of the effective date of
the above-referenced Registration Statement for Thursday, December 14, 2017, at 5:00 p.m. Eastern Time, in accordance with Rule
461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective
at this time and we hereby formally withdraw our request for acceleration of the effective date.
AKERS BIOSCIENCES, INC.
By:
/s/ John J. Gormally
John J. Gormally
Chief Executive Officer